These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23405830)

  • 1. SCN5A splicing variants and the possibility of predicting heart failure-associated arrhythmia.
    Gao G; Dudley SC
    Expert Rev Cardiovasc Ther; 2013 Feb; 11(2):117-9. PubMed ID: 23405830
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced risk profiling of implanted defibrillator shocks with circulating SCN5A mRNA splicing variants: a pilot trial.
    Gao G; Brahmanandam V; Raicu M; Gu L; Zhou L; Kasturirangan S; Shah A; Negi SI; Wood MR; Desai AA; Tatooles A; Schwartz A; Dudley SC
    J Am Coll Cardiol; 2014 Jun; 63(21):2261-9. PubMed ID: 24703920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the arrhythmogenic substrate in human heart failure.
    Partemi S; Batlle M; Berne P; Berruezo A; Campos B; Mont L; Riuró H; Roig E; Pérez-Villa F; Ortiz J; Pascali VL; Oliva A; Brugada R; Brugada J
    Cardiovasc Pathol; 2013; 22(2):133-40. PubMed ID: 23036686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare sudden unexpected death in epilepsy SCN5A variants cause changes in channel function implicating cardiac arrhythmia as a cause of death.
    Soh MS; Bagnall RD; Semsarian C; Scheffer IE; Berkovic SF; Reid CA
    Epilepsia; 2022 Jun; 63(6):e57-e62. PubMed ID: 35397174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.
    Freyermuth F; Rau F; Kokunai Y; Linke T; Sellier C; Nakamori M; Kino Y; Arandel L; Jollet A; Thibault C; Philipps M; Vicaire S; Jost B; Udd B; Day JW; Duboc D; Wahbi K; Matsumura T; Fujimura H; Mochizuki H; Deryckere F; Kimura T; Nukina N; Ishiura S; Lacroix V; Campan-Fournier A; Navratil V; Chautard E; Auboeuf D; Horie M; Imoto K; Lee KY; Swanson MS; de Munain AL; Inada S; Itoh H; Nakazawa K; Ashihara T; Wang E; Zimmer T; Furling D; Takahashi MP; Charlet-Berguerand N
    Nat Commun; 2016 Apr; 7():11067. PubMed ID: 27063795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HuR-mediated SCN5A messenger RNA stability reduces arrhythmic risk in heart failure.
    Zhou A; Xie A; Kim TY; Liu H; Shi G; Kang GJ; Jiang N; Liu M; Jeong EM; Choi BR; Dudley SC
    Heart Rhythm; 2018 Jul; 15(7):1072-1080. PubMed ID: 29454929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging cardiac SCN5A using the novel F-18 radiotracer radiocaine.
    Hooker JM; Strebl MG; Schroeder FA; Wey HY; Ambardekar AV; McKinsey TA; Schoenberger M
    Sci Rep; 2017 Feb; 7():42136. PubMed ID: 28205593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKII Phosphorylation of Na(V)1.5: Novel in Vitro Sites Identified by Mass Spectrometry and Reduced S516 Phosphorylation in Human Heart Failure.
    Herren AW; Weber DM; Rigor RR; Margulies KB; Phinney BS; Bers DM
    J Proteome Res; 2015 May; 14(5):2298-311. PubMed ID: 25815641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic triggers associated with Sudden Cardiac Death.
    Abdelsayed M; Peters CH; Ruben PC
    Channels (Austin); 2018 Jan; 12(1):76-77. PubMed ID: 28976236
    [No Abstract]   [Full Text] [Related]  

  • 12. Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms.
    Rivaud MR; Delmar M; Remme CA
    Cardiovasc Res; 2020 Jul; 116(9):1557-1570. PubMed ID: 32251506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBM25/LUC7L3 function in cardiac sodium channel splicing regulation of human heart failure.
    Gao G; Dudley SC
    Trends Cardiovasc Med; 2013 Jan; 23(1):5-8. PubMed ID: 22939879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of sodium channels as a novel proarrhythmic mechanism in the human failing heart.
    Dybkova N; Ahmad S; Pabel S; Tirilomis P; Hartmann N; Fischer TH; Bengel P; Tirilomis T; Ljubojevic S; Renner A; Gummert J; Ellenberger D; Wagner S; Frey N; Maier LS; Streckfuss-Bömeke K; Hasenfuss G; Sossalla S
    Cardiovasc Res; 2018 Nov; 114(13):1728-1737. PubMed ID: 29931291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an N-terminal Na
    Scheiper-Welling S; Zuccolini P; Rauh O; Beckmann BM; Geisen C; Moroni A; Thiel G; Kauferstein S
    BMC Med Genet; 2020 Nov; 21(1):227. PubMed ID: 33213388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias.
    Herren AW; Bers DM; Grandi E
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H431-45. PubMed ID: 23771687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
    Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed diagnostic criteria for the Brugada syndrome: consensus report.
    Wilde AA; Antzelevitch C; Borggrefe M; Brugada J; Brugada R; Brugada P; Corrado D; Hauer RN; Kass RS; Nademanee K; Priori SG; Towbin JA;
    Circulation; 2002 Nov; 106(19):2514-9. PubMed ID: 12417552
    [No Abstract]   [Full Text] [Related]  

  • 19. Heritability in a SCN5A-mutation founder population with increased female susceptibility to non-nocturnal ventricular tachyarrhythmia and sudden cardiac death.
    Ter Bekke RMA; Isaacs A; Barysenka A; Hoos MB; Jongbloed JDH; Hoorntje JCA; Patelski ASM; Helderman-van den Enden ATJM; van den Wijngaard A; Stoll M; Volders PGA
    Heart Rhythm; 2017 Dec; 14(12):1873-1881. PubMed ID: 28782696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiogram changes and atrial arrhythmias in individuals carrying sodium channel SCN5A D1275N mutation.
    Vanninen SUM; Nikus K; Aalto-Setälä K
    Ann Med; 2017 Sep; 49(6):496-503. PubMed ID: 28294644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.